$COO

The Cooper Companies stock (US2166481027): Drops 0.80% to $59.47

The Cooper Companies stock (COO) dropped 0.80% to $59.47 on May 13, 2026, marking a 27.4% year-to-date decline. Despite the recent dip, the company, specializing in vision care and surgical devices, maintains strong fundamentals and net margins, outperforming some competitors in the healthcare sector. Investors are watching its performance in the growing US healthcare market.

Original reporting
AD HOC NEWS · editorial team
Published May 14, 2026, 10:51 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 14, 2026, 11:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
The Cooper Companies stock (US2166481027): Drops 0.80% to $59.47 — source image
Decision brief

The 30-second read

$COONeutralLow
01

Why it matters

The 0.80% drop may reflect short-term profit-taking or sector adjustments, with no immediate fundamental concerns.

02

Market read

The news is relevant primarily to investors in healthcare, especially those with exposure to COO.

03

What to watch

Potential upcoming earnings reports or sector-wide regulatory changes could influence stock performance.

Timing: short-term

Background

The Cooper Companies operates in vision care and surgical devices, with recent stock decline amid broader healthcare sector fluctuations.

Company-level read

Ticker impact

$COONeutralMedium confidence
Context

The news pertains directly to Cooper Companies (COO), highlighting a recent stock decline.

Expected impact

Likely minimal impact on long-term valuation; short-term volatility may persist.

Evidence & confidence

The stock's recent decline is modest and within typical market fluctuations, with no immediate fundamental concerns.

Market effects

The healthcare sector may experience slight volatility; specific to vision care and surgical devices.

Limited regional impact, primarily US-focused.

Minimal global market implications.

Counterpoint

The decline could signal upcoming challenges in the healthcare sector or company-specific issues, warranting caution.

Key entities

  • The Cooper Companies

    A healthcare company specializing in vision care and surgical devices.

  • AD HOC NEWS

    Provider of financial news and market updates.

Related articles

$COOMedAI 8/10

Natixis Advisors LLC Buys 270,476 Shares of The Cooper Companies, Inc. $COO

Natixis Advisors LLC increased its stake in The Cooper Companies by buying 270,476 shares in Q4, bringing holdings to 303,456 shares, according to its latest SEC 13F. The position was valued at about $24.9M (~0.15%). Separately, the article notes Cooper’s fiscal Q2 EPS of $1.21 (vs $1.10 consensus) and revenue of $1.08B, plus FY2026 EPS guidance of $4.58–$4.66.

$COOMedAI 9/10

CooperCompanies (COO) Reports Q1: Everything You Need To Know Ahead Of Earnings

CooperCompanies (COO) is set to report Q1 earnings Thursday after the bell. The company reported Q1 revenue of $1.02B, up 6.2% year over year, and met revenue expectations; it beat full-year EPS guidance, with organic revenue in line. For Q1, analysts expect 5.1% revenue growth. CooperCompanies shares are down 3.3% over a month; the average analyst price target is $88.21 vs. $59.50.

$RTXMedAI 8/10

The winners in China's missile leap

RTX and Lockheed Martin are key players in the U.S. missile production buildup, with RTX winning a $22.9B Navy deal and Lockheed holding a $58.6B Patriot agreement. Both companies have multi-year contracts. Analysts see 9.26% upside for RTX and 12.20% for Lockheed. Production capacity is a key risk.

$NVDALow

Jensen Huang Said Nvidia's $30 Billion OpenAI Investment Might Be the Last. Nvidia Just Guaranteed Up to $105 Billion of OpenAI's Leases.

Nvidia's CEO, Jensen Huang, stated that a $30B investment in OpenAI might be the last, as OpenAI plans to go public. Nvidia later committed to backing up to $105B of OpenAI's data center leases. The guarantees are contingent on OpenAI's insolvency or lease defaults, with reimbursement agreements in place. Nvidia's Q1 revenue was $81.6B, up 85% YoY, with Q2 guidance at $91B.